Recent Advances in Nanoenzymes Based Therapies for Glioblastoma: Overcoming Barriers and Enhancing Targeted Treatment
Top Cited Papers
Open Access
- 24 January 2025
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 12 (10) , e2413367
Abstract
Glioblastoma multiforme (GBM) is a highly aggressive and malignant brain tumor originating from glial cells, characterized by high recurrence rates and poor patient prognosis. The heterogeneity and complex biology of GBM, coupled with the protective nature of the blood–brain barrier (BBB), significantly limit the efficacy of traditional therapies. The rapid development of nanoenzyme technology presents a promising therapeutic paradigm for the rational and targeted treatment of GBM. In this review, the underlying mechanisms of GBM pathogenesis are comprehensively discussed, emphasizing the impact of the BBB on treatment strategies. Recent advances in nanoenzyme‐based approaches for GBM therapy are explored, highlighting how these nanoenzymes enhance various treatment modalities through their multifunctional capabilities and potential for precise drug delivery. Finally, the challenges and therapeutic prospects of translating nanoenzymes from laboratory research to clinical application, including issues of stability, targeting efficiency, safety, and regulatory hurdles are critically analyzed. By providing a thorough understanding of both the opportunities and obstacles associated with nanoenzyme‐based therapies, future research directions are aimed to be informed and contribute to the development of more effective treatments for GBM.Keywords
Funding Information
- Clinical Trial Center, China Medical University Hospital (22585401)
This publication has 169 references indexed in Scilit:
- Blood‐Brain Barrier‐Penetrating Metal‐Organic Framework Antioxidant Nanozymes for Targeted Ischemic Stroke TherapyAdvanced Healthcare Materials, 2024
- Simultaneous Modulation of Hypoxia And Metabolism in Glioblastoma for Enhanced Radio‐ImmunotherapyAdvanced Functional Materials, 2023
- Glioblastoma and Other Primary Brain Malignancies in AdultsJAMA, 2023
- Engineered Nanoenzymes with Multifunctional Properties for Next‐Generation Biological and Environmental ApplicationsAdvanced Functional Materials, 2021
- Fe(III)‐Porphyrin Sonotheranostics: A Green Triple‐Regulated ROS Generation Nanoplatform for Enhanced Cancer Imaging and TherapyAdvanced Functional Materials, 2019
- Photosensitizers for Photodynamic TherapyAdvanced Healthcare Materials, 2019
- Nanoparticles Surmounting Blood–Brain Tumor Barrier Through Both Transcellular and Paracellular Pathways to Target Brain MetastasesAdvanced Functional Materials, 2019
- Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T CellsAdvanced Materials, 2019
- Designing Next‐Generation Local Drug Delivery Vehicles for Glioblastoma Adjuvant Chemotherapy: Lessons from the ClinicAdvanced Healthcare Materials, 2019
- Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological DiseasesAdvanced Materials, 2018